tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IOBT Stock Latest News

IO Biotech price target raised to $6 from $4 at Morgan Stanley
The FlyIO Biotech price target raised to $6 from $4 at Morgan Stanley
4d ago
IOBT
IO Biotech announces results from Phase 2 trial of IO102-IO103
PremiumThe Fly
IO Biotech announces results from Phase 2 trial of IO102-IO103
5d ago
IOBT
IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer
PremiumPress Releases
IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer
6d ago
IOBT
IO Biotech price target lowered to $4 from $7 at Morgan Stanley
PremiumThe Fly
IO Biotech price target lowered to $4 from $7 at Morgan Stanley
17d ago
IOBT
IO Biotech’s Promising Phase 3 Cancer Vaccine Trial Advances
PremiumCompany Announcements
IO Biotech’s Promising Phase 3 Cancer Vaccine Trial Advances
21d ago
8K
IOBT
IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
PremiumPress ReleasesIO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
21d ago
IOBT
IO Biotech says IDMC recommends continuation of IO102-IO103 trial
Premium
The Fly
IO Biotech says IDMC recommends continuation of IO102-IO103 trial
21d ago
MRK
IOBT
IO Biotech Announces Participation in Upcoming Investor Conferences
Premium
Press Releases
IO Biotech Announces Participation in Upcoming Investor Conferences
25d ago
IOBT
IO Biotech reports Q2 EPS (31c) vs (74c) last year
PremiumThe Fly
IO Biotech reports Q2 EPS (31c) vs (74c) last year
1M ago
IOBT
IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights
PremiumPress Releases
IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights
1M ago
IOBT
IOBT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
IOBT Upcoming Earnings Report: What to Expect?
1M ago
IOBT
IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024
PremiumPress Releases
IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024
2M ago
IOBT
IO Biotech to Present at Jefferies Global Healthcare Conference
PremiumPress ReleasesIO Biotech to Present at Jefferies Global Healthcare Conference
4M ago
IOBT
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
Premium
Press Releases
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
4M ago
IOBT
IO Biotech sees cash runway into 4Q25
Premium
The Fly
IO Biotech sees cash runway into 4Q25
4M ago
IOBT
IO Biotech reports Q1 EPS (30c), consensus (36c)
PremiumThe Fly
IO Biotech reports Q1 EPS (30c), consensus (36c)
4M ago
IOBT
IOBT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
IOBT Upcoming Earnings Report: What to Expect?
4M ago
IOBT
IO Biotech Board Member Jack Nielsen Resigns Due to Health
PremiumCompany Announcements
IO Biotech Board Member Jack Nielsen Resigns Due to Health
5M ago
8K
IOBT
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
5M ago
IOBT
IO Biotech participates in a conference call with Jefferies
PremiumThe FlyIO Biotech participates in a conference call with Jefferies
5M ago
IOBT
IO Biotech appoints Shamsaei as SVP, Commercial Development
Premium
The Fly
IO Biotech appoints Shamsaei as SVP, Commercial Development
5M ago
ALLO
IOBT
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
Premium
Press Releases
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
5M ago
IOBT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >